Many medical schools are running away from industry, but one university is embracing the outcomes of working with Industry. The Dean of the University of South Florida is hosting on March 4th Nobel Laureate Alfred Gilman, MD, PhD in a lecture titled:
Why is Everyone Picking on the Pharmaceutical Industry
And Yes, I have a Financial Conflict of Interest
A pro and con discussion of the pharmaceutical industry’s current status,
Including consideration of public affairs issues
Cocktail Reception: 5:00pm-7:00pm
Lecture: 7:00pm-8:00pm
Sponsored by USF Health
In addition they are also holding a panel discussion on the important topic of transparency and objectivity:
Tenth USF Symposium on Bioethics Conflicts of Interest
Balancing Entrepreneurship with Objectivity and Transparency
University of South Florida Discussion with Alfred Gilman, MD, PhD
Panel Discussion: 3:00pm-5:00pm
Jointly Sponsored by
USF Division of Research Integrity & Compliance &
USF Bioethics and Medical Humanities
Registration
For more information and to register visit
No registration fee for these activities.
Registrations must be received by March 1st
About Lecturer:
Alfred Gilman, MD, PhD
1994 Nobel Laureate in Physiology or Medicine
Alfred G. Gilman, MD, PhD co-founded Regeneron Pharmaceuticals, Inc and is currently the Chief Scientific Officer of the Cancer Prevention and Research Institute of Texas.
He served as Executive Vice President for Academic Affairs and Provost at the University of Texas Southwestern Medical Center in Dallas as well as Dean of Southwestern Medical School. Dr. Gilman is an American biochemist who shared the 1994 Nobel Prize in Physiology or Medicine with Martin Rodbell for their discovery of G-proteins and their role in signal transduction within the cell.
He received a Bachelor of Science degree summa cum laude in Biochemistry from Yale University and his Doctor of Medicine and Doctorate in Pharmacology degrees from Case Western Reserve University in Cleveland, Ohio.
Dr. Gilman has been the recipient of many awards including the American Heart Association Basic Science Research Prize in 1990, American Cancer Society Medal of Honor in 1995, Albert Lasker Basic Medical Research Award in 1989, and The Gairdner Foundation International Award in 1984.